STEPHANIE ALEXANDER: Open Payments
NPI 1225754781 · NEWBURGH, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,124 in 58 payments from 20 companies in 2025. Trend: 2023 $584 · 2024 $797 · 2025 $1,124
Food & beverage: $1,124
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $337 |
| Janssen Biotech, Inc. | 7 | $165 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $105 |
| Regeneron Healthcare Solutions, Inc. | 3 | $67 |
| Madrigal Pharmaceuticals | 2 | $66 |
| Ardelyx, Inc. | 3 | $52 |
| Gilead Sciences, Inc. | 2 | $45 |
| GENZYME CORPORATION | 1 | $34 |
| Lilly USA, LLC | 2 | $30 |
| Phathom Pharmaceuticals, Inc. | 2 | $29 |
Products named: TREMFYA, RINVOQ, XIFAXAN, DUPIXENT, REZDIFFRA, MAVYRET, IBSRELA, EPKINLY.
Industry payments across IN — which companies pay providers there.
